The stock surged. Revenue of $1.04 billion topped analysts’ calls for $1.02 billion, according to FactSet. The figure ...

DexCom, Inc. (NASDAQ: DXCM) has once again demonstrated its formidable position in the continuous glucose monitoring (CGM) ...

DexCom (DXCM) might move higher on growing ... Shares of the medical technology company climbed 16% to $81.42 on Friday and were headed for their largest same-day percentage increase since Oct ...

Dexcom (Nasdaq:DXCM) announced today that it promoted Jake Leach to the role of president, in addition to his post as COO.

Glucose tracking is a natural part of Oura’s $75 million investment from Dexcom.

Devices like Dexcom’s Stelo and Abbott’s Lingo are no longer just for people managing diabetes with a prescription – they’re now available to anyone who wants insight into how blood sugar ...

Importantly, we made these commercial investments knowing that new Dexcom technology and broader access were just around the corner. Since that time, we introduced Stelo as the first over-the ...

So even in these challenging times, it's a good idea to look for stocks worth investing in for the next decade and beyond.

Dexcom (NASDAQ:DXCM) announced today that it expanded its partnership with Oura, officially launching an integration with ...

Ōura, maker of a health-monitoring smart ring, announced that it will use AI to track and analyze two new metabolic health features: meals and glucose.

Live Updates Live Coverage Has Ended Stocks Widen Lead 3:51 pm by Stocks have widened their lead headed into the weekend, ...

DexCom appears poised not only to maintain but also expand its dominance in the rapidly evolving and increasingly vital diabetes technology landscape, offering a strong outlook for investors ...